Literature DB >> 9433935

A subset of CD8+ T cells from allergic patients produce IL-4 and stimulate IgE production in vitro.

N Meissner1, F Kussebi, T Jung, H Ratti, C Baumgarten, T Werfel, C Heusser, H Renz.   

Abstract

BACKGROUND AND
OBJECTIVE: A subset of IL-4 producing CD8+ T cells was recently identified in HIV patients. Based on these findings we examined whether IL-4 producing CD8+ T cells would also be present in allergic patients and what would be the functional relevance of this T-cell population.
METHODS: We investigated the role of CD8+ T cells in IgE production of allergic diseases by analysing the cytokine profile of individual CD4+ and CD8+ T cells.
RESULTS: In allergic patients about twice as many CD4+ T cells and six times as many CD8+ T cells produced IL-4 as in non-allergic controls. In contrast the frequency of IFNgamma+ T-cell subsets did not significantly differ between the allergic and non-allergic individuals. The frequency of IL4+ CD8+ T cells correlated with the level of serum IgE. Coculture experiments with T cells or purified CD8+ T cells together with autologous B cells indicated that CD8+ T cells enhanced IgE in vitro, but not IgM production, even when they were physically separated from B cells. This effect could be partially blocked by addition of an IL-4 binding protein, a soluble IL-4 receptor indicating that IL-4 is involved in CD8+ T-cell mediated IgE production.
CONCLUSIONS: These data indicate a positive role of IL-4 secreting CD8+ T cells in IgE regulation in allergic patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9433935     DOI: 10.1046/j.1365-2222.1997.1180931.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  5 in total

Review 1.  Perennial allergic rhinitis and keratoconjunctivitis.

Authors:  J P Rihoux
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.

Authors:  K Bendelja; A Gagro; A Bace; R Lokar-Kolbas; V Krsulovic-Hresic; V Drazenovic; G Mlinaric-Galinovic; S Rabatic
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 3.  Immunotherapy for allergies and asthma: present and future.

Authors:  Shyam S Mohapatra; Momina Qazi; Gary Hellermann
Journal:  Curr Opin Pharmacol       Date:  2010-06-21       Impact factor: 5.547

4.  Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases.

Authors:  Qing Ye; Xiao-Jun Xu; Wen-Xia Shao; Yan-Xiang Pan; Xue-Jun Chen
Journal:  ScientificWorldJournal       Date:  2014-04-07

5.  Allergic diseases in subjects under 18 years living with HIV.

Authors:  Leandro S Linhar; Jefferson Traebert; Dayani Galato; Rosemeri M da Silva; Fabiana Schuelter-Trevisol; Natália S Rovaris; Jane da Silva
Journal:  Allergy Asthma Clin Immunol       Date:  2014-07-07       Impact factor: 3.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.